Aβ (Pimplikar, 2009) . Results from clinical trials have shown that removing plaques will not reverse the damage or stop the Alzheimer's dementia (Cappai and Barnham, 2008; Hardy, 2009) . Recent evidence suggests that this toxicity may be linked to the aggregation state of the peptide, implicating oligomers, rather than insoluble fibrils, as the primary toxic species (Baglioni et al., 2006; Haass and Selkoe, 2007) . Although both are found in the brains of postmortem AD patients, soluble Aβ oligomers are better correlated with disease severity than are the classic amyloid plaques containing insoluble Aβ fibrillar deposits (Lue et al., 1999; McLean et al., 1999; Tomic et al., 2009) . Furthermore, oligomers are found both extracellularly and intracellularly, and are capable of moving between the interior of the cell and the extracellular space (Takahashi et al., 2004; Gaspar et al., 2010) . However, Aβ oligomer structure, size, conformation, and interrelationships with other amyloid aggregates, as well as the exact mechanism of Aβ oligomer-induced neurotoxicity, remain elusive (Caughey and Lansbury, 2003; Ross and Poirier, 2005; Glabe, 2006) . Monomeric Aβ undergoes conformation transitions and proceeds to form low molecular weight oligomers (dimer/trimer), and then soluble high molecular weight aggregates and progresses to form spherical oligomers that are composed of 12-24 monomers, which prolong to protofibrils and finally become insoluble fibrils (Glabe, 2008) . These various structures differ not only in aggregation state, but also in their toxic effects. Recently, many have reported that fibrils, which were once thought to exhibit the highest levels of toxicity, are actually second in toxicity to intermediate aggregates of Aβ (spherical oligomers and protofibrils) (Glabe, 2006; Glabe and Kayed, 2006) .
Our studies demonstrated the presence of a variety of Aβ oligomer conformations (Glabe, 2008) . The different conformations can be produced by several pathways and simple manipulation of conditions in which Aβ aggregates, and underline the complexity of the mechanism of oligomer formation (Kayed et al., , 2009 ; Glabe and Kayed, 2006; Kayed and Glabe, 2006; Necula et al., 2007; Glabe, 2008) . Moreover, several studies suggest that oligomeric species differ not only in the mechanism of formation, but also in the mechanism of toxicity (Cizas et al., 2010; Zako, 2010) .
Mechanism Involved in β-Amyloid Oligomer Toxicity

Receptor-mediated β-amyloid oligomer neurotoxicity
Extracellular Aβ oligomers bind the cell surface, leading to functional disruption of a number of receptors, including the N -methyl-D-aspartate receptor (NMDAR) and others ( Fig. 1.1) , resulting Figure 1.1. β-Amyloid (Aβ) oligomer neurotoxicity can be mediated through their ability to bind multiple receptors leading to the activation of various signaling pathways. Two possibilities may explain the lack of receptor specificity: (1) Aβ oligomers are indeed "sticky" as they have been reported as having a detergent-like quality, making it easier for them to be promiscuous in their interactions; and (2) oligomers are heterogeneous as indicated by colors and each oligomeric species has high affinity to a specific receptor or membrane protein.
in synaptic dysfunction and neurodegeneration. A number of possible mechanisms and targets are under investigation, including the abnormal activation of signaling pathways.
Recently, Yamamoto et al. (2007) suggested that Aβ oligomers induce nerve growth factor (NGF) receptor-mediated neuronal death. NGF can induce cell death through the p75 neurotrophin receptor (p75NTR), a member of the tumor necrosis factor receptor superfamily (Hansma et al., 1995) . A previous report supports this concept, demonstrating that Aβ-derived diffusible ligands (ADDLs) potently alter NGF-mediated signaling in cultured cells (Chromy et al., 2003) . Moreover, several studies suggested that Aβ toxicity is produced through the association with p75NTR (Rabizadeh et al., 1994; Yaar et al., 1997 Yaar et al., , 2002 Kuner et al., 1998; Perini et al., 2002; Tsukamoto et al., 2003; Costantini et al., 2005) . Specifically, Aβ toxicity mediated by p75NTR depends on a death domain (Bothwell, 1996) in the cytoplasmic part of p75NTR molecules (Costantini et al., 2005) . However, it has also been demonstrated that p75NTR promotes the survival and differentiation of vertebrate neurons, indicating that p75NTR might have diverse functions in both cell death and cell survival (Dechant and Barde, 2002) . It should be noted that conflicting evidence also exists regarding the role of p75NTR against the toxicity of Aβ oligomers. Costantini et al. (2005) showed that soluble oligomers of Aβ exert cytotoxic activity independent of p75NTR and that the expression of p75NTR exerts a protective role against the toxic activity of soluble oligomers. The authors also concluded that this role is due to an active function of the juxtamembrane sequence of the cytoplasmic region of p75NTR and that the protective function is mediated by phosphatidylinositide 3-kinase activity. In another study, it was observed that low levels of extracellular Aβ increase the levels of p75NTR in primary cultures of human neurons. Unexpectedly, it was found that p75NTR protects primary human neurons against Aβ-induced toxicity (Zhang et al., 2003) . These opposite conclusions imply that the signaling pathways of p75NTR are complicated and that the functions of p75NTR vary depending on several factors.
Other reports on neuronal receptor-mediated toxicity mechanisms have shown that Aβ disturbs NMDAR-dependent long-term potentiation induction in vivo and in vitro. Furthermore, these studies suggest that Aβ specifically interferes with several major signaling pathways downstream of NMDAR, including the Ca 2+ -dependent protein phosphatase calcineurin, Ca 2+ /calmodulin-dependent protein kinase II (CaMKII), protein phosphatase 1, and cAMP response element-binding protein (reviewed in Yamin, 2009) . In another study of downstream NMDAR effectors, Zhao et al. (2004) determined that low molecular weight oligomeric Aβ could also inhibit CaMKII and thereby disrupt the dynamic balance in place between protein kinase and phosphatase, presumed to be critical during synaptic plasticity. In another study, it was found that ADDLs stimulated excessive formation of reactive oxygen species (ROS) through a mechanism requiring NMDAR activation. ADDL binding to neurons was reduced and ROS formation was completely blocked by an antibody to the extracellular domain of the NR1 sub-unit of NMDARs (De Felice et al., 2007) . The authors showed that the mechanism of ADDL-stimulated ROS formation requires ADDL targeting and activation of NMDARs, leading to a rapid increase in neuronal calcium levels. Taken together, these observations suggest that dysregulation of NMDAR function induced by ADDL binding to neuronal synapses may lead to synaptic mitochondrial dysfunction and excessive ROS formation. Shankar et al. (2007) found that Aβ oligomers decrease spine density through a pathway that requires NMDARs, calcineurin, and cofilin. These results suggest that the Aβ oligomer mimics a state of partial NMDAR blockade, by reducing NMDAR activation, reducing NMDARdependent calcium influx, or enhancing NMDAR-dependent activation of calcineurin. It has also been shown that signal transduction by neuronal insulin receptors (IRs) is strikingly sensitive to disruption by soluble Aβ oligomers. In a recent study it was found that ADDLs caused a rapid and substantial loss of neuronal surface IRs specifically on dendrites bound by ADDLs. Removal of dendritic IRs was associated with increased receptor immunoreactivity in the cell body, indicating redistribution of the receptors (Zhao et al., 2008) . The results presented by the authors identify novel factors that affect neuronal IR signaling and suggest that insulin resistance in the AD brain is a response to ADDLs, which disrupt insulin signaling. Townsend et al. (2007) found that soluble Aβ binds to IR and interferes with its insulin-induced autophosphorylation. Taken together, these data demonstrate that physiologically relevant levels of naturally secreted Aβ interfere with IR function and prevent the rapid activation of specific kinases required for long-term potentiation. De Felice et al. (2009) also suggest that ADDLs caused major downregulation of plasma membrane IRs, via a mechanism sensitive to CaMKII and casein kinase II inhibition. Magdesian et al. (2008) showed that Aβ oligomers bind to the Frizzled (Fz) cysteine-rich domain at or in close proximity to the Wnt-binding site and inhibit the canonical Wnt signaling pathway. Wnts are secreted glycoproteins that bind to and signal through Fz receptors and mediate cell-cell communication (Dann et al., 2001 ). Wnt signaling regulates a variety of critical biological processes, including development, cell movement, cell polarity, axon guidance, and synapse formation (Gordon and Nusse, 2006) . Magdesian et al. (2008) concluded that Aβ oligomers bind to Fz receptors, producing the inhibition of Wnt signaling, which causes tau phosphorylation and neurofibrillary tangles; which suggests a Wnt/β-catenin toxicity pathway. A recent study by Lauren et al. (2009) identifies the cellular prion protein (PrP C ) as an Aβ oligomer receptor. The authors demonstrated that PrP C is a mediator of Aβ oligomerinduced synaptic dysfunction and that Aβ oligomers bind with nanomolar affinity to PrP C , but the interaction does not require the infectious PrP Sc conformation. The binding of Aβ oligomers to PrP C receptor may disrupt the interaction between PrP C and co-receptor, such as NMDAR.
Despite the fact that Aβ oligomers have been strongly implicated in neuronal dysfunction and neurotoxicity in AD, the signal transduction mechanisms involved in the neuronal impact of Aβ oligomers remain to be fully elucidated. A major unknown is the identity of the neuronal receptor(s) that binds Aβ oligomers and mediates neuronal dysfunction. As we described above, several studies postulate a great number of possible receptors involved in the toxicity of Aβ oligomers, but some of these studies are contradictory. The final identification of a highly specific receptor(s) for Aβ oligomers would provide considerable insight into mechanisms of pathogenesis and might reveal novel opportunities for the development of strategies to combat AD.
Impairment of the cellular membrane by β-amyloid oligomers
The maintenance of plasma membrane integrity is critical for cell viability, as the membrane controls the exchange of materials between the cell and its surrounding environment. An increase in membrane permeability and intracellular calcium concentration has long been associated with amyloid pathogenesis, although questions remain as to the mechanism underlying these observations (Mattson et al., 1992; Mattson, 1994) . One explanation for the molecular mechanism of neurodegeneration induced by Aβ specifically is channel formation and disruption of calcium homeostasis. Arispe et al. (1993a,b) demonstrated the incorporation of Aβ peptides into artificial lipid bilayers to form cation-specific channels. Furthermore, others reported cytosolic calcium elevations as a result of this channel formation by Aβ, but also by other amyloid-forming proteins (Kawahara et al., 2000) ; the results of this study strongly suggest that incorporation of Aβ into membranes and the subsequent pore formation may be the primary events in Aβ neurotoxicity. Specifically, the authors suggested that, after being incorporated into the membrane, Aβ will change its structure and accumulated Aβ become aggregated on the membranes. They also suggested the possibility that the ratio of cholesterol to phospholipids in the membrane alters membrane fluidity and therefore affects the process. Microcircumstances on the membranes, such as the presence of rafts, may influence this process (Kawahara et al., 2000) . These data and other reports culminated in what came to be known as the "channel hypothesis", implicating amyloid peptide channels in the pathogenic ion dysregulation observed in degenerative disease (Kagan et al., 2002 (Kagan et al., , 2004 . In this respect, Aβ may share this mechanism of toxicity with the similar mechanism underlying the toxicity of various antimicrobial or antifungal peptides, such as alamethicin, gramicidin, magainin 2, and melittin, which also exhibit channel-forming ability and cell toxicity (Bechinger, 1997) . Once Aβ channels are formed on neuronal membranes, the disruption of calcium and other-ion homeostasis may promote numerous degenerative processes, including free radical formation (Yatin et al., 1998) , and phosphorylation of tau (Takashima et al., 1993) , thereby accelerating neurodegeneration. The free radicals also induce membrane disruption, by which unregulated calcium influx is amplified and a vicious circle is initiated. In contrast to the amyloid channel hypothesis, recent data suggest that homogeneous solutions of amyloid oligomers increase the conductance of artificial lipid bilayers, but do not exhibit channel-like properties. Specifically, the conductance changes observed did not occur in discrete steps; rather, oligomers appeared to enhance ion mobility across the lipid bilayer independently (Kayed et al., 2004) . This increased conductivity was not ion specific, and thus has the potential to depolarize the membrane and lead to cellular dysfunction. A growing body of evidence points to membrane permeabilization by amyloid oligomers as a common mechanism of pathogenesis in amyloid-related degenerative diseases (Hannig et al., 2000; Volles et al., 2001; Caughey and Lansbury, 2003; Porat et al., 2003; Stefani and Dobson, 2003; Green et al., 2004; Kayed et al., 2004 Kayed et al., , 2009 Klein et al., 2004; Walsh and Selkoe, 2004; Demuro et al., 2005; Canale et al., 2006; Lashuel and Lansbury, 2006; Sokolov et al., 2006; Valincius et al., 2008; Butterfield and Lashuel, 2010) . These studies suggest that membrane permeabilization caused by amyloid oligomers is due to defects in the lipid bilayer, rather than the formation of discrete proteinaceous pores. In accordance with this observation, a study by Demuro et al. (2005) showed that amyloid oligomers consistently produce rapid and dramatic elevations in Ca 2+ , whereas equivalent concentrations of monomers or fibrils do not. The action of amyloid oligomers appears to involve a channel-independent disruption of the integrity of both plasma and intracellular membranes. The authors propose that amyloid oligomers exert an immediate action by increasing the permeability of the plasma membrane and subsequently penetrate cells, as proposed previously (Bucciantini et al., 2004) , where they similarly disrupt intracellular membranes to cause leakage of sequestered Ca 2+ . In another study we reported that soluble oligomers from several types of amyloid specifically increase lipid bilayer conductance regardless of the sequence, whereas fibrils and soluble low molecular weight species have no effect. The increase in membrane conductance occurs without any evidence of discrete channel or pore formation or ion selectivity (Kayed et al., 2004) . The results presented in this study indicate that soluble oligomers from many types of amyloidogenic proteins and peptides increase membrane conductance in a conformation-specific fashion and suggest that this may represent the common primary mechanism of pathogenesis in amyloid-related degenerative diseases. The increase in membrane conductivity could lead to depolarization of the plasma membrane, which would be detrimental to the function of cells and especially so for neuronal function. The membrane conductance increase that we reported can also account for a wide range of effects, such as defects of cytosolic ion homeostasis and signaling as a direct consequence of the membrane conductance increase (Mattson et al., 1993) . Other experiments suggested that amyloid oligomers break down or reduce the normal dielectric barrier to ion translocation provided by the hydrocarbon region of the lipid bilayer (Sokolov et al., 2006) . The authors proposed that Aβ oligomers increase membrane conductance and permeability to charged species by spreading apart the lipid headgroups and consequently thinning the bilayer and lowering the permeability barrier (Neumcke and Lauger, 1969; Parsegian, 1969) .
The formation of non-specific Aβ pores or channels ( Fig. 1. 2) on neuronal membranes in the AD brain causes the disruption of calcium and other-ion homeostasis, which may promote numerous degenerative processes, including free radical formation (Yatin et al., 1998) , and phosphorylation of tau (Takashima et al., 1993) , and thereby accelerate neurodegeneration and cell death. The free radicals also induce membrane disruption, by which unregulated calcium influx is amplified and a vicious circle is initiated.
Intracellular β-amyloid oligomer toxicity
In addition to extracellular Aβ, there is a large body of evidence to demonstrate that Aβ accumulates intracellularly (Glabe, 2001; LaFerla et al., 2007; Gouras et al., 2010) . Intraneuronal Aβ accumulation has been identified in AD patients, transgenic mice, and cultured cells (LaFerla et al., 1997; Skovronsky et al., 1998; Gouras et al., 2000; D'Andrea et al., 2001; Gyure et al., 2001; Wirths et al., 2001; Langui et al., 2004) . Intraneuronal Aβ accumulation appears prior to extracellular amyloid plaque formation and results in synaptic dysfunction (Skovronsky et al., 1998; Mucke et al., 2000; D'Andrea et al., 2001; Mori et al., 2002; Takahashi et al., 2002; Oddo et al., 2003; Casas et al., 2004; Moolman et al., 2004; Almeida et al., 2005; Spires et al., 2005) . A key question that remains to be addressed is whether the intracellular Aβ builds up because a portion of the generated Aβ is not secreted and consequently remains intracellular, or alternatively, whether secreted Aβ is taken back up by the cell to form these intracellular pools (Yang et al., 1995 (Yang et al., , 1999 Burdick et al., 1997; Bahr et al., 1998) . It is well known that APP is also localized in the trans-Golgi network (Xu et al., 1995) , endoplasmic reticulum, and endosomal, lysosomal (Kinoshita et al., 2003) , and mitochondrial membranes (Mizuguchi et al., 1992) . The liberation of Aβ could potentially occur wherever APP and the β-and γ-secretases are localized, and it is likely that this occurs in several cellular compartments. In addition to Aβ being produced intracellularly, previously secreted Aβ that forms an extracellular Aβ pool can be taken up by cells and internalized into intracellular pools through various receptors and transporters ( Fig. 1.3) . A recent study showed that, in mice with a toxin-induced compromise of the blood-brain barrier, fluorescently labeled Aβ that is injected into the tail vein can accumulate intracellularly in pyramidal neurons in the cerebral cortex (Clifford et al., 2007) . The results presented by the authors provide direct evidence that neurons can take up extracellular Aβ; one of the mechanisms that has been proposed is the endocytocis of Aβ oligomers (Yu et al., 2010) . The intracellular accumulation of â-amyloid (Aâ) oligomers and other aggregates causes many key pathological events of Alzheimer's disease including proteasome impairment, mitochondrial dysfunction, disturbance of autophagy, the production of reactive oxygen species, lipid peroxidation, disruption of lysosomal membrane, and the breakdown of many cellular processes. RAGE: receptor for advanced glycation end products; α7nAChR: α7 nicotinic acetylcholine receptor; APOE: apolipoprotein E.
It is well known that Aβ binds to the α7 nicotinic acetylcholine receptor (α7nAChR) with high affinity, and that this binding results in receptor internalization and accumulation of Aβ intracellularly (Wang et al., 2000; Nagele et al., 2002) . These findings were recently confirmed in a study using the mouse model 3xTg-AD, where the authors show a loss of the α7nAChRs restricted to brain regions that accumulate intraneuronal Aβ (Oddo et al., 2005) . Recently, the analyses of a novel animal model A7KO-APP revealed the significance of α7nAChR in AD and its protective role from Aβ oligomer toxicity in early-stage AD. Analysis in early-stage preplaque cognitive decline revealed neurodegeneration in the A7KO-APP hippocampus. These changes occurred concomitant with the appearance of a dodecameric oligomer of Aβ that was absent from all other genotypic groups (Hernandez et al., 2010) .
Several studies have shown that apolipoprotein E (APOE) receptors, which are members of the low-density lipoprotein receptor family, modulate Aβ production and cellular uptake (Bu et al., 2006) . The low-density lipoprotein receptor-related protein, which is another member of this family of receptors, binds to Aβ directly, or through ligands such as APOE, and undergoes rapid endocytosis, facilitating Aβ uptake (Bu et al., 2006) . It is well known that APOE ε4 is the major genetic risk factor for AD, and it is remarkable that one of its functions appears to be to mediate directly the accumulation of intracellular Aβ. It has been reported that Aβ is internalized through the scavenger receptor for advanced glycation end products (RAGE), in neurons and microglia (Yan et al., 1996; Sasaki et al., 2001; Deane et al., 2003) . The binding of Aβ to RAGE in neurons initiated a cascade of events that produces oxidative stress and nuclear factor-κ B activation, which induces the production of macrophage colonystimulating factor (Du Yan et al., 1997) and an enhanced microglial response. Additionally, it has been shown that RAGE-Aβ complexes are internalized and that they co-localize with the lysosomal pathway in astrocytes in AD patients (Sasaki et al., 2001) .
The toxicity mechanism of intracellular Aβ oligomers remains unclear. Almeida et al. (2006) demonstrated that in APP mutant transgenic mice and in human AD brains, progressive intraneuronal accumulation of Aβ occurs, especially in multivesicular bodies. The authors provided evidence that Aβ accumulation in neurons inhibits the activities of the proteasome and deubiquitinating enzymes. These data suggest a mechanism whereby Aβ accumulation in neurons impairs the multivesicular body sorting pathway via the ubiquitin-proteasome system in AD. Indeed, the authors hypothesize that the inhibition of the ubiquitin-proteasome system by Aβ impairs the endocytic trafficking of neuronal receptors and thereby may be the cause of synaptic dysfunction in AD. Furthermore, several other studies suggest that an inhibition of the proteasome leads to an increase of Aβ levels (Oh et al., 2005; Tseng et al., 2008) . Recent studies by LaFerla's group have shown proteasome inhibition in the 3xTg-AD mice at ages at which oligomeric Aβ accumulation is seen within neuronal cell bodies (Rosario et al., 2006; Tseng et al., 2008) . These findings show that oligomeric Aβ accumulation within neuronal cell bodies has pathological consequences, as proteasome impairment led to the build-up of tau protein. Another study, by Mousnier et al. (2007) , reported a possible prefolding-mediated proteasomal protein-degradation pathway. This suggests that the Aβ oligomer-prefolding complex could cause proteasome dysfunction and subsequent cell death.
Accumulation of Aβ has also been observed in mitochondria (Manczak et al., 2006) . Progressive accumulation of intracellular Aβ in mitochondria is related to diminished enzymatic activity of respiratory chain complexes III and IV, and a reduced rate of oxygen consumption (Caspersen et al., 2005) . These observations correlated with the multiple mitochondrial defects reported in AD and mouse models of the disease (Keil et al., 2006) .
A marked disturbance of autophagy has recently been appreciated in AD (Chyung et al., 2005; Nixon et al., 2005) , adding to evidence for extensive dysfunction of the lysosomal system in this disease (Nixon and Cataldo, 2006) . Aβ can accumulate in lysosomes in the AD brain. Aβ within the lysosomal compartment destabilizes its membrane , which will lead to the release of Aβ in the cytosolic compartment.
The studies described in this section suggested that the toxicity mechanism of intracellular oligomers could be different from that produced by extracellular oligomers. However, further studies are necessary to determine the exact mechanism of toxicity produced by Aβ oligomers in AD.
Concluding Remarks
Based on the studies discussed here and the countless targets associated with toxicity of Aβ oligomers, it is conceivable that oligomers are not specific and interact with many targets, or it is possible that the toxicity is associated with the formation process rather than a specific oligomeric species; this kinetic model of toxicity (Wogulis et al., 2005) demonstrates that Aβ aggregation and the formation of the fibrils cause toxicity at low concentrations. Alternatively, we propose that Aβ oligomers possess a large number of exchangeable, still distinct conformational polymorphisms , similar to the structural polymorphisms described for Aβ fibrils (Kodali et al., 2010; Luhrs et al., 2005; Petkova et al., 2005; Miller et al., 2010) , and that different sub-groups of Aβ oligomers and fibrils induce neurotoxicity and may contribute to AD pathology via different mechanisms (Deshpande et al., 2006; Glabe, 2008; Cizas et al., 2010; Wu et al., 2010; Lasagna-Reeves et al., 2011) . The unique combination of size, hydrophobicity, and conformation of each oligomeric species determines both its toxicity and the final aggregation state (Fig. 1.4) . The existence of polymorphisms in what are now known as oligomers may be analogous to the polymorphisms that exist within yeast prions (Tanaka et al., 2006; Toyama et al., 2007) . Identifying these subtle differences between oligomers both in vitro and in vivo represents the next challenge facing the amyloid field and requires novel methods and reagents. Cappai, R. and Barnham, K.J. (2008 (2005) . Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage, J. Biol. Chem., 280, 4383-4392. Cizas, P., Budvytyte, R., Morkuniene, R., Moldovan, R., Broccio, M., Losche, M., Niaura, G., Valincius, G. and Borutaite, V. (2010) . Size-dependent neurotoxicity of beta-amyloid oligomers, Arch. Biochem. Biophys., 496, 84-92. Clifford, P.M., Zarrabi, S., Siu, G., Kinsler, K.J., Kosciuk, M.C., Venkataraman, V., D'Andrea, M.R., Dinsmore, S. and Nagele, R.G. (2007) . Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons, Brain Res., 1142, 223-236. Costantini, C., Rossi, F., Formaggio, E., Bernardoni, R., Cecconi, D. and DellaBianca, V. (2005) . Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death, J. Mol. Neurosci., 25, 141-156. D'Andrea, M.R., Nagele, R.G., Wang, H.Y., Peterson, P.A. and Lee, D.H. (2001) .
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